Yurdaydin, C. Et Al. 2022. A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis. HEPATOLOGY , vol.75, no.6 , 1551-1565.

Yurdaydin, C., Keskin, O., Yurdcu, E., Caliskan, A., Onem, S., Karakaya, F., ... Kalkan, C.(2022). A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis. HEPATOLOGY , vol.75, no.6, 1551-1565.

Yurdaydin, Cihan Et Al. "A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis," HEPATOLOGY , vol.75, no.6, 1551-1565, 2022

Yurdaydin, Cihan Et Al. "A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis." HEPATOLOGY , vol.75, no.6, pp.1551-1565, 2022

Yurdaydin, C. Et Al. (2022) . "A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis." HEPATOLOGY , vol.75, no.6, pp.1551-1565.

@article{article, author={Cihan Yurdaydin Et Al. }, title={A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis}, journal={HEPATOLOGY}, year=2022, pages={1551-1565} }